Global Hip Osteoarthritis Pain Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hip Osteoarthritis Pain Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Hip Osteoarthritis Pain Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Hip Osteoarthritis Pain Drug by Country/Region, 2017, 2022 & 2028

2.2 Hip Osteoarthritis Pain Drug Segment by Type

2.2.1 Oral

2.2.2 Injection

2.2.3 External

2.3 Hip Osteoarthritis Pain Drug Sales by Type

2.3.1 Global Hip Osteoarthritis Pain Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Hip Osteoarthritis Pain Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Hip Osteoarthritis Pain Drug Sale Price by Type (2017-2022)

2.4 Hip Osteoarthritis Pain Drug Segment by Application

2.4.1 Medical Care

2.4.2 Personal Care

2.5 Hip Osteoarthritis Pain Drug Sales by Application

2.5.1 Global Hip Osteoarthritis Pain Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Hip Osteoarthritis Pain Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Hip Osteoarthritis Pain Drug Sale Price by Application (2017-2022)

3 Global Hip Osteoarthritis Pain Drug by Company

3.1 Global Hip Osteoarthritis Pain Drug Breakdown Data by Company

3.1.1 Global Hip Osteoarthritis Pain Drug Annual Sales by Company (2020-2022)

3.1.2 Global Hip Osteoarthritis Pain Drug Sales Market Share by Company (2020-2022)

3.2 Global Hip Osteoarthritis Pain Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Hip Osteoarthritis Pain Drug Revenue by Company (2020-2022)

3.2.2 Global Hip Osteoarthritis Pain Drug Revenue Market Share by Company (2020-2022)

3.3 Global Hip Osteoarthritis Pain Drug Sale Price by Company

3.4 Key Manufacturers Hip Osteoarthritis Pain Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Hip Osteoarthritis Pain Drug Product Location Distribution

3.4.2 Players Hip Osteoarthritis Pain Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Hip Osteoarthritis Pain Drug by Geographic Region

4.1 World Historic Hip Osteoarthritis Pain Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Hip Osteoarthritis Pain Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Hip Osteoarthritis Pain Drug Annual Revenue by Geographic Region

4.2 World Historic Hip Osteoarthritis Pain Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Hip Osteoarthritis Pain Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Hip Osteoarthritis Pain Drug Annual Revenue by Country/Region

4.3 Americas Hip Osteoarthritis Pain Drug Sales Growth

4.4 APAC Hip Osteoarthritis Pain Drug Sales Growth

4.5 Europe Hip Osteoarthritis Pain Drug Sales Growth

4.6 Middle East & Africa Hip Osteoarthritis Pain Drug Sales Growth

5 Americas

5.1 Americas Hip Osteoarthritis Pain Drug Sales by Country

5.1.1 Americas Hip Osteoarthritis Pain Drug Sales by Country (2017-2022)

5.1.2 Americas Hip Osteoarthritis Pain Drug Revenue by Country (2017-2022)

5.2 Americas Hip Osteoarthritis Pain Drug Sales by Type

5.3 Americas Hip Osteoarthritis Pain Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hip Osteoarthritis Pain Drug Sales by Region

6.1.1 APAC Hip Osteoarthritis Pain Drug Sales by Region (2017-2022)

6.1.2 APAC Hip Osteoarthritis Pain Drug Revenue by Region (2017-2022)

6.2 APAC Hip Osteoarthritis Pain Drug Sales by Type

6.3 APAC Hip Osteoarthritis Pain Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Hip Osteoarthritis Pain Drug by Country

7.1.1 Europe Hip Osteoarthritis Pain Drug Sales by Country (2017-2022)

7.1.2 Europe Hip Osteoarthritis Pain Drug Revenue by Country (2017-2022)

7.2 Europe Hip Osteoarthritis Pain Drug Sales by Type

7.3 Europe Hip Osteoarthritis Pain Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hip Osteoarthritis Pain Drug by Country

8.1.1 Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Hip Osteoarthritis Pain Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Type

8.3 Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Hip Osteoarthritis Pain Drug

10.3 Manufacturing Process Analysis of Hip Osteoarthritis Pain Drug

10.4 Industry Chain Structure of Hip Osteoarthritis Pain Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Hip Osteoarthritis Pain Drug Distributors

11.3 Hip Osteoarthritis Pain Drug Customer

12 World Forecast Review for Hip Osteoarthritis Pain Drug by Geographic Region

12.1 Global Hip Osteoarthritis Pain Drug Market Size Forecast by Region

12.1.1 Global Hip Osteoarthritis Pain Drug Forecast by Region (2023-2028)

12.1.2 Global Hip Osteoarthritis Pain Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Hip Osteoarthritis Pain Drug Forecast by Type

12.7 Global Hip Osteoarthritis Pain Drug Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Hip Osteoarthritis Pain Drug Product Offered

13.1.3 Pfizer Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Johnson and Johnson

13.2.1 Johnson and Johnson Company Information

13.2.2 Johnson and Johnson Hip Osteoarthritis Pain Drug Product Offered

13.2.3 Johnson and Johnson Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Johnson and Johnson Main Business Overview

13.2.5 Johnson and Johnson Latest Developments

13.3 GlaxoSmithKline

13.3.1 GlaxoSmithKline Company Information

13.3.2 GlaxoSmithKline Hip Osteoarthritis Pain Drug Product Offered

13.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GlaxoSmithKline Main Business Overview

13.3.5 GlaxoSmithKline Latest Developments

13.4 Bayer

13.4.1 Bayer Company Information

13.4.2 Bayer Hip Osteoarthritis Pain Drug Product Offered

13.4.3 Bayer Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bayer Main Business Overview

13.4.5 Bayer Latest Developments

13.5 Eli Lilly

13.5.1 Eli Lilly Company Information

13.5.2 Eli Lilly Hip Osteoarthritis Pain Drug Product Offered

13.5.3 Eli Lilly Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Eli Lilly Main Business Overview

13.5.5 Eli Lilly Latest Developments

13.6 Novartis

13.6.1 Novartis Company Information

13.6.2 Novartis Hip Osteoarthritis Pain Drug Product Offered

13.6.3 Novartis Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis Main Business Overview

13.6.5 Novartis Latest Developments

13.7 Sanofi

13.7.1 Sanofi Company Information

13.7.2 Sanofi Hip Osteoarthritis Pain Drug Product Offered

13.7.3 Sanofi Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sanofi Main Business Overview

13.7.5 Sanofi Latest Developments

13.8 Horizon Pharma

13.8.1 Horizon Pharma Company Information

13.8.2 Horizon Pharma Hip Osteoarthritis Pain Drug Product Offered

13.8.3 Horizon Pharma Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Horizon Pharma Main Business Overview

13.8.5 Horizon Pharma Latest Developments

13.9 Abbott

13.9.1 Abbott Company Information

13.9.2 Abbott Hip Osteoarthritis Pain Drug Product Offered

13.9.3 Abbott Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Abbott Main Business Overview

13.9.5 Abbott Latest Developments

13.10 Mylan

13.10.1 Mylan Company Information

13.10.2 Mylan Hip Osteoarthritis Pain Drug Product Offered

13.10.3 Mylan Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mylan Main Business Overview

13.10.5 Mylan Latest Developments

13.11 Daiichi Sankyo

13.11.1 Daiichi Sankyo Company Information

13.11.2 Daiichi Sankyo Hip Osteoarthritis Pain Drug Product Offered

13.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Daiichi Sankyo Main Business Overview

13.11.5 Daiichi Sankyo Latest Developments

13.12 TEVA

13.12.1 TEVA Company Information

13.12.2 TEVA Hip Osteoarthritis Pain Drug Product Offered

13.12.3 TEVA Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 TEVA Main Business Overview

13.12.5 TEVA Latest Developments

13.13 Almatica Pharma

13.13.1 Almatica Pharma Company Information

13.13.2 Almatica Pharma Hip Osteoarthritis Pain Drug Product Offered

13.13.3 Almatica Pharma Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Almatica Pharma Main Business Overview

13.13.5 Almatica Pharma Latest Developments

13.14 Astellas Pharma

13.14.1 Astellas Pharma Company Information

13.14.2 Astellas Pharma Hip Osteoarthritis Pain Drug Product Offered

13.14.3 Astellas Pharma Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Astellas Pharma Main Business Overview

13.14.5 Astellas Pharma Latest Developments

13.15 Tide Pharmaceutical

13.15.1 Tide Pharmaceutical Company Information

13.15.2 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product Offered

13.15.3 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Tide Pharmaceutical Main Business Overview

13.15.5 Tide Pharmaceutical Latest Developments

13.16 Iroko Pharmaceuticals

13.16.1 Iroko Pharmaceuticals Company Information

13.16.2 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product Offered

13.16.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Iroko Pharmaceuticals Main Business Overview

13.16.5 Iroko Pharmaceuticals Latest Developments

13.17 Hengrui Pharmaceutical

13.17.1 Hengrui Pharmaceutical Company Information

13.17.2 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product Offered

13.17.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Hengrui Pharmaceutical Main Business Overview

13.17.5 Hengrui Pharmaceutical Latest Developments

13.18 Abiogen Pharma

13.18.1 Abiogen Pharma Company Information

13.18.2 Abiogen Pharma Hip Osteoarthritis Pain Drug Product Offered

13.18.3 Abiogen Pharma Hip Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Abiogen Pharma Main Business Overview

13.18.5 Abiogen Pharma Latest Developments

14 Research Findings and Conclusion

Table 1. Hip Osteoarthritis Pain Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Hip Osteoarthritis Pain Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral

Table 4. Major Players of Injection

Table 5. Major Players of External

Table 6. Global Hip Osteoarthritis Pain Drug Sales by Type (2017-2022) & (K Units)

Table 7. Global Hip Osteoarthritis Pain Drug Sales Market Share by Type (2017-2022)

Table 8. Global Hip Osteoarthritis Pain Drug Revenue by Type (2017-2022) & ($ million)

Table 9. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Type (2017-2022)

Table 10. Global Hip Osteoarthritis Pain Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Hip Osteoarthritis Pain Drug Sales by Application (2017-2022) & (K Units)

Table 12. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application (2017-2022)

Table 13. Global Hip Osteoarthritis Pain Drug Revenue by Application (2017-2022)

Table 14. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Application (2017-2022)

Table 15. Global Hip Osteoarthritis Pain Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Hip Osteoarthritis Pain Drug Sales by Company (2020-2022) & (K Units)

Table 17. Global Hip Osteoarthritis Pain Drug Sales Market Share by Company (2020-2022)

Table 18. Global Hip Osteoarthritis Pain Drug Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Company (2020-2022)

Table 20. Global Hip Osteoarthritis Pain Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Hip Osteoarthritis Pain Drug Producing Area Distribution and Sales Area

Table 22. Players Hip Osteoarthritis Pain Drug Products Offered

Table 23. Hip Osteoarthritis Pain Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Hip Osteoarthritis Pain Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Hip Osteoarthritis Pain Drug Sales Market Share Geographic Region (2017-2022)

Table 28. Global Hip Osteoarthritis Pain Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Hip Osteoarthritis Pain Drug Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Hip Osteoarthritis Pain Drug Sales Market Share by Country/Region (2017-2022)

Table 32. Global Hip Osteoarthritis Pain Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Hip Osteoarthritis Pain Drug Sales by Country (2017-2022) & (K Units)

Table 35. Americas Hip Osteoarthritis Pain Drug Sales Market Share by Country (2017-2022)

Table 36. Americas Hip Osteoarthritis Pain Drug Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2017-2022)

Table 38. Americas Hip Osteoarthritis Pain Drug Sales by Type (2017-2022) & (K Units)

Table 39. Americas Hip Osteoarthritis Pain Drug Sales Market Share by Type (2017-2022)

Table 40. Americas Hip Osteoarthritis Pain Drug Sales by Application (2017-2022) & (K Units)

Table 41. Americas Hip Osteoarthritis Pain Drug Sales Market Share by Application (2017-2022)

Table 42. APAC Hip Osteoarthritis Pain Drug Sales by Region (2017-2022) & (K Units)

Table 43. APAC Hip Osteoarthritis Pain Drug Sales Market Share by Region (2017-2022)

Table 44. APAC Hip Osteoarthritis Pain Drug Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Hip Osteoarthritis Pain Drug Revenue Market Share by Region (2017-2022)

Table 46. APAC Hip Osteoarthritis Pain Drug Sales by Type (2017-2022) & (K Units)

Table 47. APAC Hip Osteoarthritis Pain Drug Sales Market Share by Type (2017-2022)

Table 48. APAC Hip Osteoarthritis Pain Drug Sales by Application (2017-2022) & (K Units)

Table 49. APAC Hip Osteoarthritis Pain Drug Sales Market Share by Application (2017-2022)

Table 50. Europe Hip Osteoarthritis Pain Drug Sales by Country (2017-2022) & (K Units)

Table 51. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Country (2017-2022)

Table 52. Europe Hip Osteoarthritis Pain Drug Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2017-2022)

Table 54. Europe Hip Osteoarthritis Pain Drug Sales by Type (2017-2022) & (K Units)

Table 55. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Type (2017-2022)

Table 56. Europe Hip Osteoarthritis Pain Drug Sales by Application (2017-2022) & (K Units)

Table 57. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Hip Osteoarthritis Pain Drug

Table 67. Key Market Challenges & Risks of Hip Osteoarthritis Pain Drug

Table 68. Key Industry Trends of Hip Osteoarthritis Pain Drug

Table 69. Hip Osteoarthritis Pain Drug Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Hip Osteoarthritis Pain Drug Distributors List

Table 72. Hip Osteoarthritis Pain Drug Customer List

Table 73. Global Hip Osteoarthritis Pain Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Hip Osteoarthritis Pain Drug Sales Market Forecast by Region

Table 75. Global Hip Osteoarthritis Pain Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Hip Osteoarthritis Pain Drug Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Hip Osteoarthritis Pain Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Hip Osteoarthritis Pain Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Hip Osteoarthritis Pain Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Hip Osteoarthritis Pain Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Hip Osteoarthritis Pain Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Hip Osteoarthritis Pain Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Hip Osteoarthritis Pain Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Hip Osteoarthritis Pain Drug Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Hip Osteoarthritis Pain Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Hip Osteoarthritis Pain Drug Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Hip Osteoarthritis Pain Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Hip Osteoarthritis Pain Drug Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Hip Osteoarthritis Pain Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Hip Osteoarthritis Pain Drug Revenue Market Share Forecast by Application (2023-2028)

Table 93. Pfizer Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 94. Pfizer Hip Osteoarthritis Pain Drug Product Offered

Table 95. Pfizer Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Pfizer Main Business

Table 97. Pfizer Latest Developments

Table 98. Johnson and Johnson Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 99. Johnson and Johnson Hip Osteoarthritis Pain Drug Product Offered

Table 100. Johnson and Johnson Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Johnson and Johnson Main Business

Table 102. Johnson and Johnson Latest Developments

Table 103. GlaxoSmithKline Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 104. GlaxoSmithKline Hip Osteoarthritis Pain Drug Product Offered

Table 105. GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. GlaxoSmithKline Main Business

Table 107. GlaxoSmithKline Latest Developments

Table 108. Bayer Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 109. Bayer Hip Osteoarthritis Pain Drug Product Offered

Table 110. Bayer Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Bayer Main Business

Table 112. Bayer Latest Developments

Table 113. Eli Lilly Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 114. Eli Lilly Hip Osteoarthritis Pain Drug Product Offered

Table 115. Eli Lilly Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Eli Lilly Main Business

Table 117. Eli Lilly Latest Developments

Table 118. Novartis Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 119. Novartis Hip Osteoarthritis Pain Drug Product Offered

Table 120. Novartis Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Novartis Main Business

Table 122. Novartis Latest Developments

Table 123. Sanofi Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 124. Sanofi Hip Osteoarthritis Pain Drug Product Offered

Table 125. Sanofi Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Sanofi Main Business

Table 127. Sanofi Latest Developments

Table 128. Horizon Pharma Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 129. Horizon Pharma Hip Osteoarthritis Pain Drug Product Offered

Table 130. Horizon Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Horizon Pharma Main Business

Table 132. Horizon Pharma Latest Developments

Table 133. Abbott Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 134. Abbott Hip Osteoarthritis Pain Drug Product Offered

Table 135. Abbott Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Abbott Main Business

Table 137. Abbott Latest Developments

Table 138. Mylan Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 139. Mylan Hip Osteoarthritis Pain Drug Product Offered

Table 140. Mylan Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Mylan Main Business

Table 142. Mylan Latest Developments

Table 143. Daiichi Sankyo Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 144. Daiichi Sankyo Hip Osteoarthritis Pain Drug Product Offered

Table 145. Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. Daiichi Sankyo Main Business

Table 147. Daiichi Sankyo Latest Developments

Table 148. TEVA Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 149. TEVA Hip Osteoarthritis Pain Drug Product Offered

Table 150. TEVA Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. TEVA Main Business

Table 152. TEVA Latest Developments

Table 153. Almatica Pharma Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 154. Almatica Pharma Hip Osteoarthritis Pain Drug Product Offered

Table 155. Almatica Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 156. Almatica Pharma Main Business

Table 157. Almatica Pharma Latest Developments

Table 158. Astellas Pharma Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 159. Astellas Pharma Hip Osteoarthritis Pain Drug Product Offered

Table 160. Astellas Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 161. Astellas Pharma Main Business

Table 162. Astellas Pharma Latest Developments

Table 163. Tide Pharmaceutical Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 164. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product Offered

Table 165. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 166. Tide Pharmaceutical Main Business

Table 167. Tide Pharmaceutical Latest Developments

Table 168. Iroko Pharmaceuticals Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 169. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product Offered

Table 170. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 171. Iroko Pharmaceuticals Main Business

Table 172. Iroko Pharmaceuticals Latest Developments

Table 173. Hengrui Pharmaceutical Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 174. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product Offered

Table 175. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 176. Hengrui Pharmaceutical Main Business

Table 177. Hengrui Pharmaceutical Latest Developments

Table 178. Abiogen Pharma Basic Information, Hip Osteoarthritis Pain Drug Manufacturing Base, Sales Area and Its Competitors

Table 179. Abiogen Pharma Hip Osteoarthritis Pain Drug Product Offered

Table 180. Abiogen Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 181. Abiogen Pharma Main Business

Table 182. Abiogen Pharma Latest Developments

List of Figures

Figure 1. Picture of Hip Osteoarthritis Pain Drug

Figure 2. Hip Osteoarthritis Pain Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Hip Osteoarthritis Pain Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Hip Osteoarthritis Pain Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Hip Osteoarthritis Pain Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral

Figure 10. Product Picture of Injection

Figure 11. Product Picture of External

Figure 12. Global Hip Osteoarthritis Pain Drug Sales Market Share by Type in 2021

Figure 13. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Type (2017-2022)

Figure 14. Hip Osteoarthritis Pain Drug Consumed in Medical Care

Figure 15. Global Hip Osteoarthritis Pain Drug Market: Medical Care (2017-2022) & (K Units)

Figure 16. Hip Osteoarthritis Pain Drug Consumed in Personal Care

Figure 17. Global Hip Osteoarthritis Pain Drug Market: Personal Care (2017-2022) & (K Units)

Figure 18. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application (2017-2022)

Figure 19. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Application in 2021

Figure 20. Hip Osteoarthritis Pain Drug Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Company in 2021

Figure 22. Global Hip Osteoarthritis Pain Drug Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Geographic Region in 2021

Figure 24. Global Hip Osteoarthritis Pain Drug Sales Market Share by Region (2017-2022)

Figure 25. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Country/Region in 2021

Figure 26. Americas Hip Osteoarthritis Pain Drug Sales 2017-2022 (K Units)

Figure 27. Americas Hip Osteoarthritis Pain Drug Revenue 2017-2022 ($ Millions)

Figure 28. APAC Hip Osteoarthritis Pain Drug Sales 2017-2022 (K Units)

Figure 29. APAC Hip Osteoarthritis Pain Drug Revenue 2017-2022 ($ Millions)

Figure 30. Europe Hip Osteoarthritis Pain Drug Sales 2017-2022 (K Units)

Figure 31. Europe Hip Osteoarthritis Pain Drug Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Hip Osteoarthritis Pain Drug Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue 2017-2022 ($ Millions)

Figure 34. Americas Hip Osteoarthritis Pain Drug Sales Market Share by Country in 2021

Figure 35. Americas Hip Osteoarthritis Pain Drug Revenue Market Share by Country in 2021

Figure 36. United States Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Hip Osteoarthritis Pain Drug Sales Market Share by Region in 2021

Figure 41. APAC Hip Osteoarthritis Pain Drug Revenue Market Share by Regions in 2021

Figure 42. China Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Country in 2021

Figure 49. Europe Hip Osteoarthritis Pain Drug Revenue Market Share by Country in 2021

Figure 50. Germany Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Country in 2021

Figure 57. Egypt Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Hip Osteoarthritis Pain Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Hip Osteoarthritis Pain Drug in 2021

Figure 63. Manufacturing Process Analysis of Hip Osteoarthritis Pain Drug

Figure 64. Industry Chain Structure of Hip Osteoarthritis Pain Drug

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles